Coenzyme Q10
- Generic Name
- Coenzyme Q10
- Brand Names
- -
- Drug Type
- Small Molecule
- Chemical Formula
- C59H90O4
- CAS Number
- 303-98-0
- Unique Ingredient Identifier
- EJ27X76M46
- Background
Ubidecarenone, also called coenzyme Q10, is a 1,4-benzoquinone. From its name (Q10), the Q refers to the constitutive quinone group, and 10 is related to the number of isoprenyl subunits in its tail. It is a powerful antioxidant, a lipid-soluble and essential cofactor in mitochondrial oxidative phosphorylation. The ubidecarenone is the coenzyme destined for ...
- Indication
The diet supplements containing ubidecarenone are indicated, as stated in the product label, to assist individuals with cardiovascular complaints including congestive heart failure and systolic hypertension. In the product, ubidecarenone is used to increase the cardiac input as well as for the prevention of several other diseases like Parkinson, fibromyalgia...
- Associated Conditions
- Migraine
- Associated Therapies
- -
CoQ10 and D-ribose in Patients With Diastolic Heart Failure
- Conditions
- Interventions
- First Posted Date
- 2017-04-28
- Last Posted Date
- 2022-03-18
- Lead Sponsor
- University of Kansas Medical Center
- Target Recruit Count
- 216
- Registration Number
- NCT03133793
- Locations
- 🇺🇸
University of Kansas Medical Center, Kansas City, Kansas, United States
Neotililty Trial: Effect of Coenzyme Q10 on Semen Parameters in Men With Idiopathic Infertility
- First Posted Date
- 2017-04-07
- Last Posted Date
- 2018-09-17
- Lead Sponsor
- PharmEvo Pvt Ltd
- Registration Number
- NCT03104998
- Locations
- 🇵🇰
HillPark Hospital, Karachi, Pakistan
Immediate or Delayed Naturopathic Medicine in Combination With Neo-Adjuvant Chemotherapy for Breast Cancer
- Conditions
- Interventions
- First Posted Date
- 2015-07-01
- Last Posted Date
- 2018-08-01
- Lead Sponsor
- Midwestern Regional Medical Center
- Target Recruit Count
- 5
- Registration Number
- NCT02486796
Beneficial Effects of Coenzyme Q10 Treatment on the Mitochondrial Dysfunction and Oxidative Stress Associated to Atherothrombosis Developement in Antiphospholipidid Syndrome Patients
- Conditions
- Interventions
- First Posted Date
- 2014-08-18
- Last Posted Date
- 2014-08-18
- Target Recruit Count
- 50
- Registration Number
- NCT02218476
- Locations
- 🇪🇸
Hospital Universitario Reina Sofía de Córdoba, Cordoba, Andalucía, Spain
Coenzyme Q10 Supplementation in Children With Idiopathic Dilated Cardiomyopathy
- First Posted Date
- 2014-04-16
- Last Posted Date
- 2014-04-16
- Lead Sponsor
- University of Tehran
- Target Recruit Count
- 38
- Registration Number
- NCT02115581
- Locations
- 🇮🇷
Children's Medical Center, Tehran, Iran, Islamic Republic of
Efficacy of Ubiquinone and Combined Antioxidant Therapy in Non-proliferative Diabetic Retinopathy
- Conditions
- Interventions
- First Posted Date
- 2014-02-13
- Last Posted Date
- 2014-02-13
- Lead Sponsor
- University of Guadalajara
- Target Recruit Count
- 61
- Registration Number
- NCT02062034
- Locations
- 🇲🇽
Cardiovascular Research Unit, University of Guadalajara, Guadalajara, Jalisco, Mexico
Atorvastatin/CoenzymeQ10 in Congestive Heart Failure
- Conditions
- Interventions
- First Posted Date
- 2013-08-20
- Last Posted Date
- 2013-08-20
- Lead Sponsor
- Isfahan University of Medical Sciences
- Target Recruit Count
- 30
- Registration Number
- NCT01925937
- Locations
- 🇮🇷
Vice Chancellery for Research of Isfahan University of Medical Sciences, Isfahan, Iran, Isfahan, Iran, Islamic Republic of
Coenzyme Q10 and Clomiphene Citrate (CC) for Ovulation Induction in Polycystic Ovary Syndrome
- Conditions
- Interventions
- First Posted Date
- 2013-07-30
- Last Posted Date
- 2013-07-30
- Lead Sponsor
- Mansoura University
- Target Recruit Count
- 110
- Registration Number
- NCT01910766
- Locations
- 🇪🇬
Mansoura University Hospitals, Mansoura, Dakahlia, Egypt
Exploring the Effects of Coenzyme Q10 on Bioenergetics Metabolism in Geriatric Bipolar Depression
- First Posted Date
- 2011-07-11
- Last Posted Date
- 2017-12-07
- Lead Sponsor
- Mclean Hospital
- Target Recruit Count
- 19
- Registration Number
- NCT01390389
- Locations
- 🇺🇸
McLean Hospital, Belmont, Massachusetts, United States
Coenzyme Q10 in Post-Cardiac Arrest Cerebral Resuscitation
- Conditions
- Interventions
- First Posted Date
- 2011-03-21
- Last Posted Date
- 2017-07-31
- Lead Sponsor
- Beth Israel Deaconess Medical Center
- Target Recruit Count
- 10
- Registration Number
- NCT01319110
- Locations
- 🇺🇸
Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.